Literature DB >> 29605901

Right ventricular septomarginal trabeculation hypertrophy is associated with disease severity in patients with pulmonary arterial hypertension.

Yang Dong1, Jiayu Sun2, Dan Yang1, Juan He1, Wei Cheng2, Ke Wan1, Hong Liu1, Andreas Greiser3, Xiaoyue Zhou4, Yuchi Han5, Yucheng Chen6.   

Abstract

To characterize the morphological change in the right ventricle (RV) of patients with pulmonary artery hypertension (PAH) and further explore the correlation between septomarginal trabeculation (SMT) and right ventricular (RV) function, myocardial fibrosis, and exercise capacity in patients with PAH. Sixty untreated PAH patients were prospectively included from May 2016 to April 2017. All patients underwent comprehensive clinical evaluation and cardiac magnetic resonance (CMR). The area and diameter of the basal segment of SMT, and the mass of SMT were measured on cine SSFP images. Relationship between parameters of SMT and RV ejection fraction (RVEF), 6 min walking distance (6MWD), myocardial fibrosis and pulmonary vascular resistance (PVR) were evaluated by Pearson's correlation and logistic regression. Predictive performance of SMT parameters for reduced RVEF or impaired 6MWD was evaluated by receiver operating characteristics (ROC) analysis. Compared with SMT diameter index and mass index, SMT area index (SMT Ai) in basal segment was the best parameter to show correlation with RVEF (r = - 0.496, P < 0.001), 6MWD (r = - 0.619, P < 0.001), and inferior insertion point (I IP) extracelluar volume (ECV) (r = 0.365, P = 0.008). ROC showed that SMT Ai had the strongest predictive value for reduced RVEF (AUC = 0.756), and impaired 6MWD (AUC = 0.813). SMT parameters were closely correlated with RV systolic function and 6MWD in patients with PAH. SMT Ai is a simple imaging indicator for the severity of PAH.

Entities:  

Keywords:  Cardiac magnetic resonance; Exercise capacity; Myocardial fibrosis; Pulmonary artery hypertension; Right ventricle; Septomarginal trabeculation

Mesh:

Year:  2018        PMID: 29605901     DOI: 10.1007/s10554-018-1347-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  30 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Authors:  Kevin G Blyth; Bjoern A Groenning; Thomas N Martin; John E Foster; Patrick B Mark; Henry J Dargie; Andrew J Peacock
Journal:  Eur Heart J       Date:  2005-05-17       Impact factor: 29.983

3.  Determination of body surface area and formulas to estimate body surface area using the alginate method.

Authors:  Joo-Young Lee; Jeong-Wha Choi; Ho Kim
Journal:  J Physiol Anthropol       Date:  2008-03       Impact factor: 2.867

4.  Association of native T1 times with biventricular function and hemodynamics in precapillary pulmonary hypertension.

Authors:  Yin Yin Chen; Hong Yun; Hang Jin; De Hong Kong; Yu Liang Long; Cai Xia Fu; Shan Yang; Meng Su Zeng
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-17       Impact factor: 2.357

5.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

Review 6.  Endogenous contrast MRI of cardiac fibrosis: beyond late gadolinium enhancement.

Authors:  Joep W M van Oorschot; Johannes M I H Gho; Gerardus P J van Hout; Martijn Froeling; Sanne J Jansen Of Lorkeers; Imo E Hoefer; Pieter A Doevendans; Peter R Luijten; Steven A J Chamuleau; Jaco J M Zwanenburg
Journal:  J Magn Reson Imaging       Date:  2014-08-05       Impact factor: 4.813

7.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Daniel Messroghli; Florian Andre; Dirk Lossnitzer; Sebastian Seitz; Marius Keller; Philipp A Schnabel; Evangelos Giannitsis; Grigorios Korosoglou; Hugo A Katus; Henning Steen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-22       Impact factor: 6.875

8.  Morphogenetic aspects of the septomarginal trabecula in the human heart.

Authors:  Adam Kosiński; Dariusz Kozłowski; Janusz Nowiński; Ewa Lewicka; Alicja Dąbrowska-Kugacka; Grzegorz Raczak; Marek Grzybiak
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

9.  Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

Authors:  Benjamin H Freed; Mardi Gomberg-Maitland; Sonal Chandra; Victor Mor-Avi; Stuart Rich; Stephen L Archer; E Bruce Jamison; Roberto M Lang; Amit R Patel
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

10.  Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure.

Authors:  Antonio Vitarelli; Enrico Mangieri; Claudio Terzano; Carlo Gaudio; Felice Salsano; Edoardo Rosato; Lidia Capotosto; Simona D'Orazio; Alessia Azzano; Giovanni Truscelli; Nino Cocco; Rasul Ashurov
Journal:  J Am Heart Assoc       Date:  2015-03-19       Impact factor: 5.501

View more
  2 in total

Review 1.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

2.  Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.

Authors:  Alessandro Giollo; Raluca B Dumitru; Peter P Swoboda; Sven Plein; John P Greenwood; Maya H Buch; Jacqueline Andrews
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-14       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.